Skip to main content
Fig. 1 | Antimicrobial Resistance & Infection Control

Fig. 1

From: Extended-spectrum β-lactamase, plasmid-mediated AmpC β-lactamase, fluoroquinolone resistance, and decreased susceptibility to carbapenems in Enterobacteriaceae: fecal carriage rates and associated risk factors in the community of Northern Cyprus

Fig. 1

Flow chart of the study protocol. Abbreviations: ESBL, extended-spectrum β-lactamase; pAmpC, plasmid-mediated AmpC β-lactamase; FQ, fluoroquinolone; MC agar, MacConkey agar; CTX, cefotaxime; CAZ, ceftazidime; CIP, ciprofloxacin; ERT, ertapenem; CD test, combined disc test; DD test, disk diffusion test; FOX, cefoxitin; OFX, ofloxacin; NOR, norfloxacin; LVX, levofloxacin, GEM, gemifloxacin, MEM, meropenem; IMP, imipenem; MBL, metallo-β-lactamase; DDST test, double disc synergy test; KPC, Klebsiella pneumoniae carbapenemase

Back to article page